Cargando…
Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer
BACKGROUND: COVID-19 has become a significant health threat and a primary healthcare concern among the most vulnerable patients with cancer. Patients with COVID-19 who have lung cancer are at great risk and need careful monitoring if they are affected. This study aimed to investigate the clinical ch...
Autores principales: | Maki, Masatoshi, Takada, Ryo, Taniguchi, Akihiko, Nomura, Naoyuki, Kuramoto, Seiichiro, Chiko, Yuki, Okada, Toshiaki, Saito, Seiji, Tamura, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624015/ https://www.ncbi.nlm.nih.gov/pubmed/36316726 http://dx.doi.org/10.1186/s40780-022-00259-6 |
Ejemplares similares
-
Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus
por: Chiko, Yuki, et al.
Publicado: (2022) -
Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study
por: Takada, Ryo, et al.
Publicado: (2023) -
Longitudinal Strain and Troponin I Elevation in Patients Undergoing Immune Checkpoint Inhibitor Therapy
por: Tamura, Yudai, et al.
Publicado: (2022) -
Possible mechanisms of cholesterol elevation aggravating COVID-19
por: Tang, Yan, et al.
Publicado: (2021) -
Genome-wide DNA methylation analysis revealed stable DNA methylation status during decidualization in human endometrial stromal cells
por: Maekawa, Ryo, et al.
Publicado: (2019)